Dizal to Highlight its Portfolio Advances in Hematologic Malignancies and Lung Cancer at ASCO 2025
DZD8586 demonstrated significant anti-tumor efficacy in heavily pretreated chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) patients with ORR of 84.2% DZD6008, a BBB-penetrant 4th generation EGFR TKI, showed encouraging and durable...
Six Abstracts of Kelun-Biotech's Clinical Studies Published at the 2025 ASCO Annual Meeting
CHENGDU, China, May 23, 2025 /PRNewswire/ -- The 2025 American Society of Clinical Oncology (ASCO) Annual Meeting is scheduled to take place in Chicago, Illinois, USA from May 30 to June 3. Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (6990.HK,...
Nona Biosciences Collaboration Partner Pfizer Announces Presentation of Phase 1 Clinical Study Design on MesoC2, an MSLN-Targeting ADC, at the 2025 ASCO Annual Meeting
CAMBRIDGE, Mass., May 23, 2025 /PRNewswire/ -- Nona Biosciences, a global biotechnology company providing integrated solutions from "Idea to IND" (I to ITM), today announced that its collaborator, Pfizer, will present an abstract detailing the...
ZHITAI, YMTC's Retail Storage Brand, Set for COMPUTEX Taipei 2025 Debut
Our product line, featuring SSDs, portable SSDs, and memory cards, comprehensively meets users' daily storage needs TAIPEI, May 22, 2025 /PRNewswire/ -- YMTC (Yangtze Memory Technologies Corp.), a memory solution provider headquartered in Wuhan,...
MGM x RR1HK Culinary Masters Returns to Macau For Its Third Edition
A 10-Michelin-Star Epicurean Adventure Through East Asia to Attract Premium Travelers to Macau MACAU, May 19, 2025 /PRNewswire/ -- After two highly acclaimed editions in partnership with Robb Report Hong Kong, MGM is excited to present the third...
Amorepacific and Johns Hopkins School of Medicine's Joint Research Program 'NBRI' Participants Present Latest Findings
Skin anti-aging and immunity effects of Amorepacific's two proprietary ingredients, 'RE.D Flavonoid' and 'Senomune' revealed at the 2025 SID Annual Meeting SEOUL, South Korea, May 16, 2025 /PRNewswire/ -- Amorepacific has demonstrated the efficacy...
"Made-in-Shanghai" will Land in Osaka Showcasing Shanghai's Fashion Ecosystem in May
OSAKA, Japan, May 15, 2025 /PRNewswire/ -- As Chinese solar term "Grain Buds" kicks in, a summer fashion harvest is about to begin! "Made in Shanghai", Shanghai's major fashion exhibition & trade event will land in Umeda, Osaka's liveliest area...
FOR SALE BY EXPRESSION OF INTEREST: Freehold Non-Conserved Commercial Building at 562 Serangoon Road
SINGAPORE, May 15, 2025 /PRNewswire/ -- Brilliance Capital Pte. Ltd. is proud to present to the market an exceptionally rare opportunity to acquire a freehold commercial building with individual strata titles per floor at 562 Serangoon Road, a...
Taiwantrade.com Brings Taiwan's ICT Excellence to COMPUTEX 2025
TAIPEI, May 13, 2025 /PRNewswire/ -- Taiwantrade.com, Taiwan's leading B2B e-commerce platform, is excited to showcase the best of Taiwan's ICT industry at COMPUTEX 2025, taking place May 20–23 at Taipei Nangang Exhibition Center Hall 2 (TaiNEX 2)....
Abbisko Therapeutics to Present Updated Results from the Phase 2 Study of Irpagratinib in Combination with Atezolizumab for the Treatment of Advanced Hepatocellular Carcinoma at the 2025 ESMO GI Congress
SHANGHAI, May 13, 2025 /PRNewswire/ -- Abbisko Therapeutics Co., Ltd. (02256.HK) today announced that updated results from the phase 2 study of irpagratinib (ABSK011) in combination with atezolizumab for the treatment of advanced hepatocellular...